Skip to main content
Premium Trial:

Request an Annual Quote

Decode Stock to Return to Nasdaq Global Market

NEW YORK (GenomeWeb News) – Decode Genetics today said that its stock will be returned to the Nasdaq Global Market at the opening of trade on Monday, June 29.

The firm said that the reinstatement follows the Nasdaq Hearing and Listing Review Council's decision to reverse a February decision by the Listing Qualifications Panel to transfer Decode's stock to the Nasdaq Capital Market. Decode did not specify the reasons why its stock would be transferred back to the Global Market.

Just a few months ago, Decode's stock was in danger of being delisted from the Nasdaq Capital Market. The firm received a reprieve while the Nasdaq Listing and Hearing Review Council conducted a review and it continued to trade on that market.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.